Product Liability Lawyer representing plaintiffs nationwide in Pharmaceutical Litigation and drug injury cases

.avif)



Thank you for considering The Lyon Firm. At this time, we are not accepting plaintiffs related to this specific consumer issue. However, if you would like to be contacted in the future, please complete the contact form. By completing the form you will be contacted if the Firm begins accepting new cases on this matter, and you will also be included in firm news alerts related to important consumer safety and privacy issues to help keep you informed about related issues.
If you or a loved one have been affected by potentially carinogenic pharmaceutical drugs Valsartan or Losartan, we are here to help. Our skilled and dedicated legal team is ready to listen to your story, answer your questions, and provide the legal representation you deserve. Together, we can work towards ensuring that responsible parties are held accountable and that victims receive the compensation and closure they need to move forward.
Explore our resources, learn about our past successes, and take the first step toward justice. Joe Lyon and The Lyon Firm are your trusted allies in the fight against pharmaceutical negligence. Your story matters, and we are here to help you tell it.
In a toxic pharmaceutical drug lawsuit, plaintiffs may seek various types of damages to compensate for the harm they have suffered due to the use of a contaminated or harmful medication.
Here are some common types of damages that can be pursued in such lawsuits:
If you are considering a toxic pharmaceutical drug lawsuit, it is crucial to consult with an experienced attorney who specializes in pharmaceutical litigation to assess your case and determine the potential damages that may be pursued on your behalf.

.jpg)
A dangerous drug lawyer, also known as a pharmaceutical injury attorney, plays a crucial role in representing individuals who have been harmed by dangerous or defective medications.
Here’s what a dangerous drug lawyer can do for your case:
If you believe you’ve been harmed by a dangerous pharmaceutical drug, it’s essential to consult with an experienced dangerous drug lawyer who can assess your situation, guide you through the legal process, and help you seek justice and compensation for your injuries.
Experts have drawn a link from contaminated drugs to certain cancers, including:
When drug makers and large corporations are negligent and produce contaminated products that lead to serious illness and injury, legal action can be necessary. In the current corporate environment, filing lawsuits is one of the only ways to keep drug companies from selling untested and dubious pharmaceuticals in the name of profit. Pharmaceutical litigation – through a lawsuit against a drug manufacturer – helps bring awareness to these companies as to the necessary changes that need to occur in order to keep people safe a healthy while taking a certain drug.
By taking the initiative and filing drug injury lawsuits, plaintiffs can receive proper compensation and hold a corporation accountable for their negligent actions. Consumer safety depends largely on making sure companies operate within the law and within ethical boundaries.
Pharmaceutical litigation is a complex area of law that combines dense regulation, developing science, and multi-jurisdictional questions of law. Most cases involving claims of drug injury and pharmaceuticals become centralized in the federal multidistrict litigation process. Pharmaceutical litigation involving injury claims are not in most cases not class action lawsuits, but they are very similar.
Due to the volume of Valsartan cases and number of similar issues, most of these cases are handled through Multidistrict Litigation (MDL). The multidistrict litigation procedure is guided by the Judicial Panel for Multidistrict Litigation, where the case is centralized before one federal Judge for the purposes of pre-trial discovery.
The MDL process is appropriate where there are one or more common questions of fact in multiple cases pending in different federal district courts. While there often are parallel state consolidated proceedings, the federal MDL process is generally supported by both Plaintiff and Defendants in these cases.
The MDL process allows for efficiency where there are millions of pages of documents, many expert witnesses across multiple disciplines from epidemiology, pharmacology, toxicology and the specific discipline for the relevant mechanism of injury.
Although 28 USC 1407 does not specify a specific number of cases required before the formation of an MDL is appropriate, the Judicial Panel for Multidistrict Litigation reviews the Motions and conducts a hearing to determine whether consolidation is ripe given the number and location of the pending cases.
Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there: